Our Mission
To provide an environment empowering men to make informed decisions about the diagnosis and treatment of prostate cancer.
Throughout New Zealand, we offer peer support to men, and their families, who have been diagnosed with prostate cancer, and we actively promote awareness of this disease through community promotions, including our Blue September campaign month.
Sexual Health Study – Update
Since recruitment began in Australia, Ireland, New Zealand and Canada nine months ago, 694 men have enrolled in this study, 18 of which are from New Zealand! The Researchers have also started data collection for the 6-month follow-up and so far, 256 men have completed this (66% response rate).
In terms of the duration of the project, baseline recruitment will end in July 2017. We encourage men to participate in this study.
The Men and Sexual Health – Prostate Cancer study is an online survey that will take approximately 30 to 40 minutes of your time.
If you are aged over 18 years, have been diagnosed with Prostate Cancer and would like to share your experience and help other men affected, please visit www.menandprostatecancer.org
Seeking Patient Feedback
In early September 2016, Graeme Pollard was told he has inoperable prostate cancer and it has probably spread to other parts of his body.
When Pollard turned 50 he was advised by friends to get a prostate check. The tests include a blood test for prostate specific antigen (PSA) and a digital rectal examination (DRE).
His GP told him he was low-risk and the tests were unnecessary.
Pollard asked another GP for a prostate check two years ago.
He was again told the tests were unnecessary.
Have you had a similar experience? The Prostate Cancer Foundation would like to hear from you. Please click here to leave your comments.
Latest News
We are pleased to announce a new support relationship with TransNet NZ through the sales of the new, innovative “Well-Hung Support Bracket”. This new device was invented and is produced in NZ and is destined to become a standard fitting in many electrical installations across residential and commercial construction. Today an MOU was signed by… Johnson & Johnson’s Zytiga helps men newly diagnosed with advanced prostate cancer live longer, according to new findings that could expand use of the medication. Men who received hormone therapy, the recommended first-time treatment, plus Zytiga were about one-third less likely to die during two studies than those who got standard treatment alone, according to research…
New Support Relationship With TransNet NZ
Zytiga Boosts Survival in New, Severe Prostate Cancers